Congenital Heart Defects in Adults

Congenital heart defects (CHDs) are structural abnormalities of the heart present from birth, and a growing population of affected individuals now survives into adulthood due to advances in pediatric cardiac surgery and interventional techniques. This page covers the classification of CHDs encountered in adult patients, the hemodynamic mechanisms underlying each defect type, the clinical scenarios that prompt cardiology referral, and the decision boundaries that guide management. Understanding CHDs in adults is essential because unrepaired or palliated lesions carry distinct long-term risks that differ substantially from those seen in pediatric presentations.

Definition and Scope

Congenital heart defects encompass a spectrum of structural anomalies affecting the heart's chambers, valves, walls, and great vessels. The American Heart Association (AHA) estimates that approximately 1.4 million adults in the United States are living with CHD, a figure that now exceeds the pediatric CHD population — a demographic reversal driven by surgical progress over the past five decades.

The field of Adult Congenital Heart Disease (ACHD) is formally recognized as a subspecialty of cardiology. The American Board of Internal Medicine (ABIM) offers board certification in ACHD, and the American College of Cardiology (ACC) publishes dedicated guidelines for this patient population (ACC/AHA 2018 Guidelines for the Management of Adults with Congenital Heart Disease, published in Circulation). These guidelines stratify defects by complexity into three tiers:

  1. Simple complexity — isolated small ventricular septal defects (VSDs), isolated patent foramen ovale (PFO), mild pulmonary valve stenosis
  2. Moderate complexity — atrial septal defects (ASDs), atrioventricular septal defects, coarctation of the aorta, tetralogy of Fallot (repaired)
  3. Great complexity — single-ventricle physiology, transposition of the great arteries, Fontan circulation

This classification directly informs where care should be delivered. The ACC/AHA guidelines specify that patients with great complexity lesions should be managed exclusively at specialized ACHD centers. The regulatory context for cardiology encompasses the accreditation standards applied to such centers through the Adult Congenital Heart Association (ACHA) and the Intersocietal Accreditation Commission (IAC).

How It Works

Each CHD type produces hemodynamic consequences through one of three fundamental mechanisms: abnormal shunting of blood between chambers or vessels, obstruction to blood flow through a valve or vessel segment, or a combination of both (mixed lesions).

Shunt lesions — such as ASDs and VSDs — create a left-to-right pressure gradient that forces oxygenated blood back through the pulmonary circulation. Over time, chronic volume overload of the right heart and pulmonary vasculature can progress to pulmonary arterial hypertension (PAH). When pulmonary vascular resistance rises above systemic levels, shunt direction reverses (right-to-left), producing cyanosis — a condition termed Eisenmenger syndrome, classified under WHO Group 1 PAH.

Obstructive lesions — such as coarctation of the aorta or bicuspid aortic valve — impose pressure overload on the upstream cardiac chamber. Coarctation of the aorta, present in approximately 4 of every 10,000 live births (CDC, National Center on Birth Defects and Developmental Disabilities), frequently goes undiagnosed until adulthood, presenting as refractory hypertension or as an incidental imaging finding. Bicuspid aortic valve, the most common CHD in adults affecting roughly 1–2% of the population (ACC/AHA 2014 Valvular Heart Disease Guidelines), predisposes to progressive aortic stenosis, regurgitation, and aortopathy.

Complex lesions involving single-ventricle physiology — such as hypoplastic left heart syndrome palliated with the Fontan procedure — produce a non-pulsatile cavopulmonary circulation where systemic venous pressure drives pulmonary blood flow directly, without a subpulmonary ventricle. Fontan-associated liver disease (FALD) and protein-losing enteropathy are recognized late complications monitored through multidisciplinary ACHD protocols.

Diagnostic tools central to ACHD evaluation include cardiac MRI, which provides three-dimensional anatomic delineation without ionizing radiation, and cardiac catheterization and angiography for hemodynamic assessment and intervention planning.

Common Scenarios

Four presentations dominate adult CHD practice:

  1. Newly diagnosed ASD in a 35–50-year-old — presents with exertional dyspnea, right heart enlargement on echocardiogram, and a fixed split S2. Secundum ASDs are amenable to percutaneous device closure if the defect measures ≤38 mm and adequate rim tissue is present (per ACC/AHA 2018 guidelines).

  2. Repaired tetralogy of Fallot with late pulmonary regurgitation — tetralogy of Fallot, comprising 7–10% of all CHDs, is the most common cyanotic defect surviving to adulthood. Following childhood repair, pulmonary regurgitation develops progressively, leading to right ventricular dilation and risk of ventricular arrhythmias. Serial echocardiogram and cardiac MRI surveillance define the threshold for pulmonary valve replacement.

  3. Coarctation re-stenosis after childhood repair — adults with prior coarctation repair require lifelong surveillance for re-coarctation, aneurysm at the repair site, bicuspid aortic valve disease, and intracranial aneurysms. Blood pressure gradients between upper and lower extremities exceeding 20 mmHg indicate significant re-coarctation.

  4. Fontan patient with declining exercise tolerance — progressive elevation of central venous pressure produces hepatic congestion, ascites, and eventually cirrhosis. Management requires hepatology co-management and consideration of heart transplantation in appropriate candidates, as covered under lvad-and-heart-transplant.

Decision Boundaries

The central decision in ACHD management is whether a defect requires intervention, continued surveillance, or palliative management — a determination governed by lesion complexity, hemodynamic burden, symptom status, and comorbidity.

Key thresholds established by the ACC/AHA 2018 ACHD guidelines include:

Arrhythmia management in ACHD represents a distinct boundary: atrial flutter in patients with Fontan or repaired tetralogy carries higher hemodynamic risk than in structurally normal hearts, and cardiac ablation or pacemakers may be indicated at lower symptom thresholds than in the general population.

For a broader orientation to how cardiology services are organized and what specialist roles are involved in ACHD care, the cardiology overview at the site index provides foundational context. The overlap between CHD management and arrhythmias, heart valve disease, and pulmonary hypertension makes ACHD one of the most multidisciplinary domains within cardiology.

References

The law belongs to the people. Georgia v. Public.Resource.Org, 590 U.S. (2020)